Signaling by Type I and II cytokine receptors: ten years after
Current Opinion in Immunology, ISSN: 0952-7915, Vol: 13, Issue: 3, Page: 363-373
2001
- 188Citations
- 106Captures
- 3Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations188
- Citation Indexes188
- 188
- CrossRef146
- Captures106
- Readers106
- 106
- Mentions3
- References3
- Wikipedia3
Review Description
Discovered during the past ten years, Janus kinases and signal transducers and activators of transcription have emerged as critical elements in cytokine signaling and immunoregulation. Recently, knockout mice for all the members of these families have been generated, with remarkably specific outcomes. Equally exciting is the discovery of a new class of inhibitors, the suppressor of cytokine signaling family. The phenotypes of mice deficient in these molecules are also striking, underscoring the importance of negative regulation in cytokine signaling.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0952791500002284; http://dx.doi.org/10.1016/s0952-7915(00)00228-4; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0035367819&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/11406370; https://linkinghub.elsevier.com/retrieve/pii/S0952791500002284; http://linkinghub.elsevier.com/retrieve/pii/S0952791500002284; http://api.elsevier.com/content/article/PII:S0952791500002284?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0952791500002284?httpAccept=text/plain; https://zenodo.org/record/1260155; http://dx.doi.org/10.1016/s0952-7915%2800%2900228-4; https://dx.doi.org/10.1016/s0952-7915%2800%2900228-4
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know